COPD is associated with a macrophage scavenger receptor-1 gene sequence variation

Chest

Volumn 137, Issue 5, 2010, Pages 1098-1107

  Ohar, Jill A ^a   Hamilton Jr , Raymond F ^b   Zheng, Siqun ^a   Sadeghnejad, Alireza ^a   Sterling, David A ^c   Xu, Jianfeng ^a   Meyers, Deborah A ^a   Bleecker, Eugene R ^a   Holian, Andrij ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MONTANA   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MACROPHAGE SCAVENGER RECEPTOR 1; SCAVENGER RECEPTOR; TRYPSIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BINDING SITE; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL ISOLATION; CELL SURFACE; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DONOR; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; GENE SEQUENCE; GENETIC CODE; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRON; LIGAND BINDING; LUNG FUNCTION; MACROPHAGE FUNCTION; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MONOCYTE; MORBIDITY; NONSENSE MUTATION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STAINING;

EID: 77951789159     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1655     Document Type: Article

References (39)

1. Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935-939.
2. Khoury MJ, Beaty TH, Tockman MS, Self SG, Cohen BH. Familial aggregation in chronic obstructive pulmonary disease: use of the loglinear model to analyze intermediate environmental and genetic risk factors. Genet Epidemiol. 1985;2(2):155-166.
3. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(5 Pt 2):S29-S32.
4. Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax. 1998;53(2):129-136. (Pubitemid 28212140)
5. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med. 1995;152(5 Pt 1):1666-1672. (Pubitemid 3002087)
6. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645-2653. (Pubitemid 38787999)
7. Palmer LJ, Celedón JC, Chapman HA, Speizer FE, Weiss ST, Silverman EK. Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. Hum Mol Genet. 2003;12(10):1199-1210.
8. Hersh CP, DeMeo DL, Raby BA, et al. Genetic linkage and association analysis of COPD-related traits on chromosome 8p. COPD. 2006;3(4):189-194.
9. Emi M, Asaoka H, Matsumoto A, et al. Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J Biol Chem. 1993;268(3):2120-2125. (Pubitemid 23033622)
10. Xu J, Zheng SL, Komiya A, et al. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet. 2002;32(2):321-325. (Pubitemid 36067428)
11. Sadeghnejad A, Meyers DA, Bottai M, Sterling DA, Bleecker ER, Ohar JA. IL13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung function. Am J Respir Crit Care Med. 2007;176(8):748-752. (Pubitemid 47598475)
12. Ohar J, Sterling DA, Bleecker E, Donohue J. Changing patterns in asbestos-induced lung disease. Chest. 2004;125(2):744-753. (Pubitemid 38223658)
13. International Labour Office. ILO International Classification of Radiographs of Pneumoconiosis:Occupational Safety and Health Series, No. 22 revised. Geneva, Switzerland: International Labour Organization, 1980.
14. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations . Am Rev Respir Dis. 1981;123(6):659-664.
15. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107-1136.
16. Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2007. www.goldcopd.org. Accessed March 18, 2010.
17. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000;161(2 Pt 1):381-390. (Pubitemid 30129442)
18. Takahashi K. Development and differentiation of macrophages and their related cells [In Japanese]. Hum Cell. 1994;7(3):109-115.
19. Naito M. Macrophage heterogeneity in development and differentiation . Arch Histol Cytol. 1993;56(4):331-351.
20. Takahashi K, Naito M, Takeya M. Development and heterogeneity of macrophages and their related cells through their differentiation pathways. Pathol Int. 1996;46(7):473-485. (Pubitemid 26299464)
21. Silverman EK, Palmer LJ, Mosley JD, et al. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet. 2002;70(5):1229-1239. (Pubitemid 34450572)
22. The National Emphysema Treatment Trial Research Group. Rationale and design of The National Emphysema Treatment Trial:a prospective randomized trial of lung volume reduction surgery. Chest. 1999;116(6):1750-1761.
23. Costabel U, Guzman J. Effect of smoking on bronchoalveolar lavage constituents. Eur Respir J. 1992;5(7):776-779.
24. Hoidal JR, Niewoehner DE. Lung phagocyte recruitment and metabolic alterations induced by cigarette smoke in humans and in hamsters. Am Rev Respir Dis. 1982;126(3):548-552.
25. Di Stefano A, Capelli A, Lusuardi M, et al. Severity of air-flow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med. 1998;158(4):1277-1285. (Pubitemid 28489033)
26. Tetley TD. Macrophages and the pathogenesis of COPD. Chest. 2002;121(5 Suppl):156S-159S.
27. Barnes PJ. Alveolar macrophages as orchestrators of COPD. COPD. 2004;1(1):59-70.
28. Tomita K, Caramori G, Lim S, et al. Increased p21 (CIPI/WAF1) and B cell lymphoma Leukemia-x (L) expression and reduced apoptosis in alveolar macrophages from smokers. Am J Respir Crit Care Med. 2002;166(5):724-731. (Pubitemid 34971857)
29. Traves SL, Smith SJ, Barnes PJ, Donnelly LE. Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2. J Leukoc Biol. 2004;76(2):441-450.
30. Kirkham PA, Spooner G, Ffoulkes-Jones C, Calvez R. Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor. Free Radic Biol Med. 2003;35(7):697-710. (Pubitemid 37329473)
31. Santiago-García J, Kodama T, Pitas RE. The class A scavenger receptor binds to proteoglycans and mediates adhesion of macrophages to the extracellular matrix. J Biol Chem. 2003;278(9):6942-6946. (Pubitemid 36800687)
32. Peiser L, Gordon S. The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. Microbes Infect. 2001;3(2):149-159. (Pubitemid 32209332)
33. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature. 1990;343(6258):531-535. (Pubitemid 20042711)
34. Rohrer L, Freeman M, Kodama T, Penman M, Krieger M. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature. 1990;343(6258):570-572. (Pubitemid 20042720)
35. Ashkenas J, Penman M, Vasile E, Acton S, Freeman M, Krieger M. Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors. J Lipid Res. 1993;34(6):983-1000. (Pubitemid 23182696)
36. Heguy A, O'Connor TP, Luettich K, et al. Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J Mol Med. 2006;84(4):318-328.
37. Bombard J, Trosclair A, Schooley M, Husten C. State-specific prevalence of current cigarette smoking among adults-United States 2002. MMWR Weekly. 2004;52(53):1277-1280.
38. Nelson DE, Emont SL, Brackbill RM, Cameron LL, Peddicord J, Fiore MC. Cigarette smoking prevalence by occupation in the United States. A comparison between 1978 to 1980 and 1987 to 1990. J Occup Med. 1994;36(5):516-525.
39. Sadeghnejad A, Ohar JA, Zheng SL, et al. Adam33 polymorphisms are associated with COPD and lung function in longterm tobacco smokers. Respir Res. 2009;10 :21.